Kyle Altman, MD
Orthopaedic Surgery · San Antonio, TXNPI 1659805596
Payments from drug & device makers
Across 89 payments — averaging $158.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Peerless Surgical Inc.$9K
- Stryker$2K
- Arthrex$796
- Zimmer Biomet$536
- Mission Medical Distribution, LLC$470
- Smith+Nephew$179
- plus $586 from 10 others
What the payments were for
- Travel & lodging$1,1738%
- Food & beverage$3,77527%
- Education$9,16365%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Peerless Surgical Inc. | 9 | $9,187 |
| Stryker | 40 | $2,359 |
| Arthrex | 8 | $796 |
| Zimmer Biomet | 3 | $536 |
| Mission Medical Distribution, LLC | 3 | $470 |
| Smith+Nephew | 4 | $179 |
| Johnson & Johnson(2 entities) | 2 | $154 |
| Melinta Therapeutics, LLC | 7 | $130 |
| Acumed LLC | 1 | $105 |
| Ferring Pharmaceuticals Inc. | 4 | $73 |
| AbbVie | 2 | $37 |
| Kowa Pharmaceuticals America, Inc. | 2 | $26 |
| Novo Nordisk | 1 | $17 |
| Bioventus LLC | 1 | $17 |
| Pacira Pharmaceuticals Incorporated | 1 | $15 |
| KCI USA, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MAKO$667
- Journey II$352
- TRIATHLON$280
- SIMPLICITI$158
- REUNION$158
- BLUEPRINT PATIENT SPECIFIC INSTRUMENTATION$130
- ARTHREX$127
- Engage Partial Knee System$117
- Legion$117
- TRITANIUM$114
- ACUMED$105
How this compares
$14,112 in reported general payments places this provider in the 70th percentile of 1,337 orthopaedic surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 67 | $560 |
| Celecoxib | 22 | $361 |
| Oxycodone Hcl | 36 | $299 |
| Pregabalin | 26 | $242 |
| Tramadol Hcl | 59 | $234 |
| Ondansetron Hcl | 43 | $209 |
| Cefadroxil | 18 | $175 |
| Meloxicam | 74 | $124 |
| Gabapentin | 18 | $100 |
| Amoxicillin | 17 | $30 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in San Antonio
- Stephen BurkhartSan Antonio$185.3M
- Michael WirthSan Antonio$4.5M
- Charles BroomeSan Antonio$3.8M
- Christopher ChaputSan Antonio$1.1M
- Ravi KariaSan Antonio$1.1M
- Charles RockwoodSan Antonio$975K
- Frank ButtacavoliSan Antonio$932K
- Robert HartzlerSan Antonio$702K
- Bernard MorreySan Antonio$639K
- Animesh AgarwalSan Antonio$440K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.